CD38 is overexpressed in several types of cancer, including prostate cancer, lung cancer, colorectal cancer, cervical cancer, and nasopharyngeal carcinoma, in which it is associated with poor prognosis 29, 69-74. Here, CD38 is linked to prostate cancer.